# Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

> **NCT02007603** · PHASE3 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 16 (actual)

## Conditions studied

- Infection During Hemodialysis

## Interventions

- **DRUG:** Administration of Amoxicillin / clavulanic acid
- **DRUG:** Ampicillin / sulbactam
- **PROCEDURE:** Blooddraws for pharmacokinetic profiling

## Key facts

- **NCT ID:** NCT02007603
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-02
- **Final completion:** 2017-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02007603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02007603, "Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02007603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*